Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care-associated infections in U.S. Hospitals. N Engl J Med. 2018;379(18):1732–44. https://doi.org/10.1056/NEJMoa1806317.
Article PubMed PubMed Central Google Scholar
Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines. Clin Infect Dis. 2016;63(5):e61–111. https://doi.org/10.1093/cid/ciw353.
Article PubMed PubMed Central Google Scholar
Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Eur Respir J. 2017;50(3):1700582. https://doi.org/10.1183/13993003.00582-2017.
Article PubMed CAS Google Scholar
Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–75. https://doi.org/10.1016/j.jinf.2020.05.046.
Article PubMed PubMed Central CAS Google Scholar
Weiner-Lastinger LM, Abner S, Edwards JR, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National healthcare safety Network, 2015–2017. Infect Control Hosp Epidemiol. 2020;41(1):1–13. https://doi.org/10.1017/ice.2019.296.
Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):e619–29. https://doi.org/10.1016/S2214-109X(18)30186-4.
European Centre for Disease Prevention and Control (ECDC). Surveillance of antimicrobial resistance in Europe 2022. Stockholm: ECDC; 2023.
Centers for Disease Control and Prevention (CDC). CDC/NHSN surveillance definitions for specific types of infections. Atlanta: CDC; 2023.
Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 2020;46(5):888–906. https://doi.org/10.1007/s00134-020-05980-0.
Article PubMed PubMed Central Google Scholar
Nseir S, Di Pompeo C, Cavestri B, et al. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease. Crit Care Med. 2006;34(12):2959–66. https://doi.org/10.1097/01.CCM.0000245661.14892.D5.
Article PubMed CAS Google Scholar
Kollef MH, Torres A, Shorr AF, et al. Nosocomial pneumonia: epidemiology, microbiology, and treatment. Semin Respir Crit Care Med. 2021;42(5):623–40. https://doi.org/10.1055/s-0041-1730920.
Clinical and Laboratory Standards Institute (CLSI). 2023. Performance standards for antimicrobial susceptibility testing. 33rd ed. CLSI supplement M100. Wayne, PA: CLSI.
Grundmann H, Glasner C, Albiger B, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae. Lancet Infect Dis. 2017;17(2):153–63. https://doi.org/10.1016/S1473-3099(16)30257-2.
Article PubMed CAS Google Scholar
IBM Corp. IBM SPSS statistics for windows (Version 26.0) [Computer software]. IBM Corp; 2019.
Cochran WG. Some methods for strengthening the common χ2 tests. Biometrics. 1954;10(4):417–51. https://doi.org/10.2307/3001616.
Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. Wiley; 2000. https://doi.org/10.1002/0471722146.
Maurice NM, Bedi B, Sadikot RT. Pseudomonas aeruginosa biofilms: host response and clinical implications. Semin Respir Crit Care Med. 2018;39(3):305–14. https://doi.org/10.1055/s-0038-1651493.
Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033. https://doi.org/10.1038/nrdp.2018.33.
Feldman C, Anderson R. The role of Streptococcus pneumoniae in community-acquired pneumonia. Semin Respir Crit Care Med. 2020;41(4):455–69. https://doi.org/10.1055/s-0040-1713372.
Clancy CJ, Nguyen MH. COVID-19, superinfections and antimicrobial development. J Antimicrob Chemother. 2021;76(4):805–7. https://doi.org/10.1093/jac/dkaa469.
Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China. Lancet Infect Dis. 2016;16(2):161–8. https://doi.org/10.1016/S1473-3099(15)00424-7.
Article PubMed CAS Google Scholar
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–41. https://doi.org/10.1086/429323.
Article PubMed CAS Google Scholar
Tozluyurt A. Molecular typing of reduced susceptibility of acinetobacter calcoaceticus–baumannii complex to chlorhexidine in Turkey by pulsed-field gel electrophoresis. J Med Microbiol. 2024;73(8):001882. https://doi.org/10.1099/jmm.0.001882.
Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–96. https://doi.org/10.1128/CMR.00064-16.
Article PubMed PubMed Central CAS Google Scholar
Giacobbe DR, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G, et al. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2021;51(1):e13319. https://doi.org/10.1111/eci.13319.
Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643. https://doi.org/10.3389/fmicb.2014.00643.
Article PubMed PubMed Central Google Scholar
Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011;35(5):736–55. https://doi.org/10.1111/j.1574-6976.2011.00268.x.
Article PubMed CAS Google Scholar
Allegranzi B, Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect. 2009;73(4):305–15. https://doi.org/10.1016/j.jhin.2009.04.019.
Article PubMed CAS Google Scholar
Falagas ME, Tansarli GS, Karageorgopoulos DE, et al. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170–5. https://doi.org/10.3201/eid2007.121004.
Article PubMed PubMed Central Google Scholar
Dyar OJ, Huttner B, Schouten J, et al. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793–8. https://doi.org/10.1016/j.cmi.2017.08.026.
Article PubMed CAS Google Scholar
Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S81–7. https://doi.org/10.1086/653053.
American Thoracic Society (ATS), Infectious Diseases Society of America (IDSA). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. https://doi.org/10.1164/rccm.200405-644ST.
Theuretzbacher U, Outterson K, Engel A, et al. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 2020;18(5):275–85. https://doi.org/10.1038/s41579-019-0288-0.
Article PubMed CAS Google Scholar
World Health Organization (WHO). WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024.
Comments (0)